Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers April 23, 2017
Pharmacy Choice - Pharmaceutical News - Valeant Pharma: FDA Approves BLA For Brodalumab Injection - April 23, 2017

Pharmacy News Article

 2/16/17 - Valeant Pharma: FDA Approves BLA For Brodalumab Injection

LONDON (dpa-AFX) - Valeant Pharmaceuticals International (VRX, VRX.TO) announced the U.S. FDA has approved the Biologics License Application for SILIQ (brodalumab) injection, for subcutaneous use, a monoclonal antibody that targets the IL-17 receptor for patients with moderate-to-severe plaque psoriasis. Valeant expects to commence sales and marketing of SILIQ in the U.S. in the second half of 2017.

The Marketing Authorisation Application for brodalumab in moderate-to-severe psoriasis was accepted by the European Medicines Agency in the fourth quarter of 2015. In August 2015, Valeant entered into a collaboration agreement with AstraZeneca (AZN) granting Valeant an exclusive license to develop and commercialize SILIQ globally, except in Japan and certain other Asian countries where rights are held by Kyowa Hakko Kirin Co., Ltd. In July 2016, AstraZeneca and Valeant amended Valeant's license for brodalumab to terminate Valeant's right to develop and commercialize brodalumab in Europe. LEO Pharma currently holds exclusive rights to develop and commercialize brodalumab in Europe, and Valeant holds the license to develop and commercialize SILIQ in the U.S and other territories, other than Japan and certain other Asian countries.



Copyright RTT News/dpa-AFX

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Apr 24: A Look Inside the Top 200 Drugs
Last Chance
Apr 25: Skin Infections: Focus on Cellulitis & MRSA
Apr 26: Medical Marijuana: Examining the Science, Not the Politics
Apr 27: What's New? New Treatments for Type 2 Diabetes
Apr 30: Using Effective Communication to Reduce Medication Errors
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415